A 68-year-old man with type 2 diabetes, CKD stage 3b, hypertension, and a recent NSTEMI. He is on metformin, ramipril, bisoprolol, atorvastatin, aspirin, and ticagrelor. His HbA1c is 64. His eGFR is 38. His blood pressure is 148/88. You need to decide whether to add an SGLT2 inhibitor, which one, and whether the renal function changes the recommendation.
This is not a textbook question. It is a Tuesday morning in general practice. And it touches at least four NICE guidelines simultaneously: NG28 (type 2 diabetes), NG136 (hypertension), CG182 (chronic kidney disease), and NG185 (acute coronary syndromes). The BNF has the dosing. SPS has the renal adjustments. Your clinical system may or may not flag the interaction.
Three tools claim to help you navigate this kind of question. They solve different layers of the same retrieval problem — and understanding which layer you need is more useful than declaring a single winner.
MetaGuideline: The Guideline Harmonisation Engine
MetaGuideline, developed by Medicaite, takes a distinctive approach. It uses a proprietary formal logic engine combined with AI to interpret and integrate thousands of individual recommendations from clinical guidelines. You input a patient scenario — the comorbidities, the medications, the clinical context — and MetaGuideline synthesises the relevant recommendations from across multiple guidelines into a single, patient-specific output.
The value proposition is harmonisation. When four guidelines apply to one patient and each contains dozens of recommendations, MetaGuideline's formal logic engine works out which recommendations apply, which conflict, and which take priority. For the cardiovascular prescribing scenario above, it would surface the NICE NG28 recommendation on SGLT2 inhibitors with proven cardiovascular benefit, cross-referenced against CKD staging thresholds and post-ACS management.
The tool is priced at £5.95 per month after a 30-day free trial, is UK-focused, and explicitly targets clinicians managing complex cardiovascular multimorbidity. It is founded by Dr Mark Thomas, a Preventive Cardiology Consultant with a PhD in cardiovascular pharmacology.
Strongest for: Multi-guideline prescribing questions where multiple NICE pathways intersect in a single patient. Cardiovascular and cardiometabolic multimorbidity in particular.
Limitations: Currently cardiovascular-focused rather than covering the full primary care curriculum. Not a general-purpose clinical reference. Not an exam preparation or learning tool.
NICE CKS: The Authoritative Source
CKS remains the definitive point-of-care summary for UK primary care. For the scenario above, you would need to open the CKS topics for type 2 diabetes, hypertension, CKD, and acute coronary syndromes separately, find the relevant sections within each, and mentally reconcile the recommendations yourself.
CKS is free, authoritative, and directly linked to NICE guidance. It is the source of truth — the resource you cite in audits, the resource that defines the standard of care.
Strongest for: Detailed, single-condition management pathways. The definitive reference when you need the full context.
Limitations: Navigating multiple CKS topics and reconciling their recommendations for a multi-morbid patient is time-consuming. CKS does not cross-reference between topics — the harmonisation is left to the clinician.
iatroX: The Citation-First AI Reference
Ask iatroX lets you type the clinical question in natural language — "Should I add an SGLT2 inhibitor to a patient with T2DM, CKD 3b, and recent NSTEMI on dual antiplatelet therapy?" — and receive a citation-first answer grounded in NICE, CKS, SIGN, and BNF content, with direct links to the primary sources.
iatroX's strength is speed and verifiability. You get a synthesised answer in seconds, with every claim linked to its guideline source. You can verify the answer against the primary NICE recommendation in one click. It is not a formal logic engine that processes every possible guideline interaction — it is an AI retrieval layer that gives you the relevant guidance fast and shows you where it came from.
Strongest for: Rapid, specific clinical questions where you need a guideline-grounded answer in 15 seconds. Guideline clarification, prescribing thresholds, referral criteria, and management pathways.
Limitations: Does not perform the deep, multi-guideline formal harmonisation that MetaGuideline's logic engine offers for complex prescribing scenarios.
When to Use Each
MetaGuideline when you are making a complex prescribing decision involving multiple NICE guidelines in a single patient, particularly in cardiovascular and cardiometabolic multimorbidity. The formal logic engine adds value precisely when the interaction between guidelines is the difficult part.
NICE CKS when you need the full, authoritative, single-condition management pathway — for audit, teaching, detailed review, or when you want to read the complete context rather than receive a synthesised answer.
iatroX when you need a fast, verified answer to a specific clinical question during a consultation. For rapid guideline clarification, prescribing threshold checks, referral criteria, and the hundred small clinical questions that arise during a busy clinic day. Also when you want to turn clinical queries into learning: iatroX's Q-Bank and CPD module convert point-of-care lookups into structured, retained knowledge.
These tools solve different layers of the same problem. The clinician who uses all three — MetaGuideline for complex prescribing harmonisation, CKS for authoritative depth, and iatroX for speed and learning — is better served than the clinician who picks one and expects it to do everything.
Conclusion
The messy UK prescribing question is messy because multiple guidelines apply simultaneously and the right answer depends on how they interact. MetaGuideline's formal logic engine addresses this directly for cardiovascular scenarios. CKS provides the authoritative source material. iatroX provides the fastest route to a guideline-grounded, citation-first answer for the specific question you need answered right now.
Different tools. Different layers. Same goal: the right prescribing decision for the patient in front of you.